Cargando…

Update in Laboratory Diagnosis of Thalassemia

Alpha- and β-thalassemias and abnormal hemoglobin (Hb) are common in tropical countries. These abnormal globin genes in different combinations lead to many thalassemic diseases including three severe thalassemia diseases, i.e., homozygous β-thalassemia, β-thalassemia/Hb E, and Hb Bart’s hydrops feta...

Descripción completa

Detalles Bibliográficos
Autores principales: Munkongdee, Thongperm, Chen, Ping, Winichagoon, Pranee, Fucharoen, Suthat, Paiboonsukwong, Kittiphong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326097/
https://www.ncbi.nlm.nih.gov/pubmed/32671092
http://dx.doi.org/10.3389/fmolb.2020.00074
_version_ 1783552276468596736
author Munkongdee, Thongperm
Chen, Ping
Winichagoon, Pranee
Fucharoen, Suthat
Paiboonsukwong, Kittiphong
author_facet Munkongdee, Thongperm
Chen, Ping
Winichagoon, Pranee
Fucharoen, Suthat
Paiboonsukwong, Kittiphong
author_sort Munkongdee, Thongperm
collection PubMed
description Alpha- and β-thalassemias and abnormal hemoglobin (Hb) are common in tropical countries. These abnormal globin genes in different combinations lead to many thalassemic diseases including three severe thalassemia diseases, i.e., homozygous β-thalassemia, β-thalassemia/Hb E, and Hb Bart’s hydrops fetalis. Laboratory diagnosis of thalassemia requires a number of tests including red blood cell indices and Hb and DNA analyses. Thalassemic red blood cell analysis with an automated hematology analyzer is a primary screening for thalassemia since microcytosis and decreased Hb content of red blood cells are hallmarks of all thalassemic red blood cells. However, these two red blood cell indices cannot discriminate between thalassemia trait and iron deficiency or between α- and β-thalassemic conditions. Today, Hb analysis may be carried out by either automatic high-performance liquid chromatography (HPLC) or capillary zone electrophoresis (CE) system. These two systems give both qualitative and quantitative analysis of Hb components and help to do thalassemia prenatal and postnatal diagnoses within a short period. Both systems have a good correlation, but the interpretation under the CE system should be done with caution because Hb A2 is clearly separated from Hb E. In case of α-thalassemia gene interaction, it can affect the amount of Hb A2/E. Thalassemia genotypes can be characterized by the intensities between alpha-/beta-globin chains or alpha-/beta-mRNA ratios. However, those are presumptive diagnoses. Only DNA analysis can be made for specific thalassemia mutation diagnosis. Various molecular techniques have been used for point mutation detection in β-thalassemia and large-deletion detection in α-thalassemia. All of these techniques have some advantages and disadvantages. Recently, screening for both α- and β-thalassemia genes by next-generation sequencing (NGS) has been introduced. This technique gives an accurate diagnosis of thalassemia that may be misdiagnosed by other conventional techniques. The major limitation for using NGS in the screening of thalassemia is its cost which is still expensive. All service labs highly recommend to select the technique(s) they are most familiar and most economic one for their routine use.
format Online
Article
Text
id pubmed-7326097
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73260972020-07-14 Update in Laboratory Diagnosis of Thalassemia Munkongdee, Thongperm Chen, Ping Winichagoon, Pranee Fucharoen, Suthat Paiboonsukwong, Kittiphong Front Mol Biosci Molecular Biosciences Alpha- and β-thalassemias and abnormal hemoglobin (Hb) are common in tropical countries. These abnormal globin genes in different combinations lead to many thalassemic diseases including three severe thalassemia diseases, i.e., homozygous β-thalassemia, β-thalassemia/Hb E, and Hb Bart’s hydrops fetalis. Laboratory diagnosis of thalassemia requires a number of tests including red blood cell indices and Hb and DNA analyses. Thalassemic red blood cell analysis with an automated hematology analyzer is a primary screening for thalassemia since microcytosis and decreased Hb content of red blood cells are hallmarks of all thalassemic red blood cells. However, these two red blood cell indices cannot discriminate between thalassemia trait and iron deficiency or between α- and β-thalassemic conditions. Today, Hb analysis may be carried out by either automatic high-performance liquid chromatography (HPLC) or capillary zone electrophoresis (CE) system. These two systems give both qualitative and quantitative analysis of Hb components and help to do thalassemia prenatal and postnatal diagnoses within a short period. Both systems have a good correlation, but the interpretation under the CE system should be done with caution because Hb A2 is clearly separated from Hb E. In case of α-thalassemia gene interaction, it can affect the amount of Hb A2/E. Thalassemia genotypes can be characterized by the intensities between alpha-/beta-globin chains or alpha-/beta-mRNA ratios. However, those are presumptive diagnoses. Only DNA analysis can be made for specific thalassemia mutation diagnosis. Various molecular techniques have been used for point mutation detection in β-thalassemia and large-deletion detection in α-thalassemia. All of these techniques have some advantages and disadvantages. Recently, screening for both α- and β-thalassemia genes by next-generation sequencing (NGS) has been introduced. This technique gives an accurate diagnosis of thalassemia that may be misdiagnosed by other conventional techniques. The major limitation for using NGS in the screening of thalassemia is its cost which is still expensive. All service labs highly recommend to select the technique(s) they are most familiar and most economic one for their routine use. Frontiers Media S.A. 2020-05-27 /pmc/articles/PMC7326097/ /pubmed/32671092 http://dx.doi.org/10.3389/fmolb.2020.00074 Text en Copyright © 2020 Munkongdee, Chen, Winichagoon, Fucharoen and Paiboonsukwong. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Munkongdee, Thongperm
Chen, Ping
Winichagoon, Pranee
Fucharoen, Suthat
Paiboonsukwong, Kittiphong
Update in Laboratory Diagnosis of Thalassemia
title Update in Laboratory Diagnosis of Thalassemia
title_full Update in Laboratory Diagnosis of Thalassemia
title_fullStr Update in Laboratory Diagnosis of Thalassemia
title_full_unstemmed Update in Laboratory Diagnosis of Thalassemia
title_short Update in Laboratory Diagnosis of Thalassemia
title_sort update in laboratory diagnosis of thalassemia
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326097/
https://www.ncbi.nlm.nih.gov/pubmed/32671092
http://dx.doi.org/10.3389/fmolb.2020.00074
work_keys_str_mv AT munkongdeethongperm updateinlaboratorydiagnosisofthalassemia
AT chenping updateinlaboratorydiagnosisofthalassemia
AT winichagoonpranee updateinlaboratorydiagnosisofthalassemia
AT fucharoensuthat updateinlaboratorydiagnosisofthalassemia
AT paiboonsukwongkittiphong updateinlaboratorydiagnosisofthalassemia